Published:
Australian gov’t invests $13.4m for highly-specialised therapies
These treatments focus on rare diseases and high-risk neuroblastoma.
The Australian government in New South Wales is set to invest $13.4m (A$20.7m) to facilitate access to highly specialised therapies.
Key treatments include CAR T-cell therapy for rare blood cancers, a gene therapy for a rare blinding eye condition, and a complex biological product for children with high-risk neuroblastoma.
The therapies are available at the Royal Prince Alfred, Westmead Hospital and the Sydney Children’s Hospitals Network.
A$1 = $0.65
Read Here
Advertise
Sign Up
